Global Orally Disintegrating Tablet Excipient Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Orally Disintegrating Tablet Excipient market size is predicted to grow from US$ 17440 million in 2025 to US$ 21600 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
LP Information, Inc. (LPI) ' newest research report, the “Orally Disintegrating Tablet Excipient Industry Forecast” looks at past sales and reviews total world Orally Disintegrating Tablet Excipient sales in 2024, providing a comprehensive analysis by region and market sector of projected Orally Disintegrating Tablet Excipient sales for 2025 through 2031. With Orally Disintegrating Tablet Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orally Disintegrating Tablet Excipient industry.
This Insight Report provides a comprehensive analysis of the global Orally Disintegrating Tablet Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orally Disintegrating Tablet Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orally Disintegrating Tablet Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orally Disintegrating Tablet Excipient and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orally Disintegrating Tablet Excipient.
This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet Excipient market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Orally Disintegrating Tablet Excipient market?
What factors are driving Orally Disintegrating Tablet Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orally Disintegrating Tablet Excipient market opportunities vary by end market size?
How does Orally Disintegrating Tablet Excipient break out by Type, by Application?
The global Orally Disintegrating Tablet Excipient market size is predicted to grow from US$ 17440 million in 2025 to US$ 21600 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
LP Information, Inc. (LPI) ' newest research report, the “Orally Disintegrating Tablet Excipient Industry Forecast” looks at past sales and reviews total world Orally Disintegrating Tablet Excipient sales in 2024, providing a comprehensive analysis by region and market sector of projected Orally Disintegrating Tablet Excipient sales for 2025 through 2031. With Orally Disintegrating Tablet Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orally Disintegrating Tablet Excipient industry.
This Insight Report provides a comprehensive analysis of the global Orally Disintegrating Tablet Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orally Disintegrating Tablet Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orally Disintegrating Tablet Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orally Disintegrating Tablet Excipient and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orally Disintegrating Tablet Excipient.
This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet Excipient market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Binders
- Glidents
- Diluents
- Disintegrants
- Others
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF
- JRS Pharma
- Roquette
- ABF Ingredients
- DFE Pharma
- Evonik
- Merck KGaA
- Ashland
- Meggle Pharma
- Shin-Etsu
- Fuji Chemical Industries
- McePharma (Vivesa holding)
- Cargill Incorporated
- Daicel Corporation
- Anhui Sunhere Pharmaceutical
What is the 10-year outlook for the global Orally Disintegrating Tablet Excipient market?
What factors are driving Orally Disintegrating Tablet Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orally Disintegrating Tablet Excipient market opportunities vary by end market size?
How does Orally Disintegrating Tablet Excipient break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Country/Region, 2020, 2024 & 2031
2.2 Orally Disintegrating Tablet Excipient Segment by Type
2.2.1 Binders
2.2.2 Glidents
2.2.3 Diluents
2.2.4 Disintegrants
2.2.5 Others
2.3 Orally Disintegrating Tablet Excipient Sales by Type
2.3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
2.3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2020-2025)
2.3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2020-2025)
2.4 Orally Disintegrating Tablet Excipient Segment by Application
2.4.1 Anti-Psychotics Drug
2.4.2 Anti-Epileptics Drug
2.4.3 Others
2.5 Orally Disintegrating Tablet Excipient Sales by Application
2.5.1 Global Orally Disintegrating Tablet Excipient Sale Market Share by Application (2020-2025)
2.5.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Application (2020-2025)
2.5.3 Global Orally Disintegrating Tablet Excipient Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Orally Disintegrating Tablet Excipient Breakdown Data by Company
3.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Company (2020-2025)
3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2020-2025)
3.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Company (2020-2025)
3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Company (2020-2025)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2020-2025)
3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Company
3.4 Key Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orally Disintegrating Tablet Excipient Product Location Distribution
3.4.2 Players Orally Disintegrating Tablet Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORALLY DISINTEGRATING TABLET EXCIPIENT BY GEOGRAPHIC REGION
4.1 World Historic Orally Disintegrating Tablet Excipient Market Size by Geographic Region (2020-2025)
4.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Orally Disintegrating Tablet Excipient Market Size by Country/Region (2020-2025)
4.2.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Country/Region (2020-2025)
4.2.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Country/Region (2020-2025)
4.3 Americas Orally Disintegrating Tablet Excipient Sales Growth
4.4 APAC Orally Disintegrating Tablet Excipient Sales Growth
4.5 Europe Orally Disintegrating Tablet Excipient Sales Growth
4.6 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Growth
5 AMERICAS
5.1 Americas Orally Disintegrating Tablet Excipient Sales by Country
5.1.1 Americas Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
5.1.2 Americas Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
5.2 Americas Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
5.3 Americas Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orally Disintegrating Tablet Excipient Sales by Region
6.1.1 APAC Orally Disintegrating Tablet Excipient Sales by Region (2020-2025)
6.1.2 APAC Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025)
6.2 APAC Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
6.3 APAC Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
7.2 Europe Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
7.3 Europe Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orally Disintegrating Tablet Excipient by Country
8.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
8.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
8.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
8.3 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet Excipient
10.3 Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
10.4 Industry Chain Structure of Orally Disintegrating Tablet Excipient
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orally Disintegrating Tablet Excipient Distributors
11.3 Orally Disintegrating Tablet Excipient Customer
12 WORLD FORECAST REVIEW FOR ORALLY DISINTEGRATING TABLET EXCIPIENT BY GEOGRAPHIC REGION
12.1 Global Orally Disintegrating Tablet Excipient Market Size Forecast by Region
12.1.1 Global Orally Disintegrating Tablet Excipient Forecast by Region (2026-2031)
12.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Orally Disintegrating Tablet Excipient Forecast by Type (2026-2031)
12.7 Global Orally Disintegrating Tablet Excipient Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 Roquette
13.3.1 Roquette Company Information
13.3.2 Roquette Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roquette Main Business Overview
13.3.5 Roquette Latest Developments
13.4 ABF Ingredients
13.4.1 ABF Ingredients Company Information
13.4.2 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ABF Ingredients Main Business Overview
13.4.5 ABF Ingredients Latest Developments
13.5 DFE Pharma
13.5.1 DFE Pharma Company Information
13.5.2 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DFE Pharma Main Business Overview
13.5.5 DFE Pharma Latest Developments
13.6 Evonik
13.6.1 Evonik Company Information
13.6.2 Evonik Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Evonik Main Business Overview
13.6.5 Evonik Latest Developments
13.7 Merck KGaA
13.7.1 Merck KGaA Company Information
13.7.2 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck KGaA Main Business Overview
13.7.5 Merck KGaA Latest Developments
13.8 Ashland
13.8.1 Ashland Company Information
13.8.2 Ashland Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ashland Main Business Overview
13.8.5 Ashland Latest Developments
13.9 Meggle Pharma
13.9.1 Meggle Pharma Company Information
13.9.2 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Meggle Pharma Main Business Overview
13.9.5 Meggle Pharma Latest Developments
13.10 Shin-Etsu
13.10.1 Shin-Etsu Company Information
13.10.2 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shin-Etsu Main Business Overview
13.10.5 Shin-Etsu Latest Developments
13.11 Fuji Chemical Industries
13.11.1 Fuji Chemical Industries Company Information
13.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fuji Chemical Industries Main Business Overview
13.11.5 Fuji Chemical Industries Latest Developments
13.12 McePharma (Vivesa holding)
13.12.1 McePharma (Vivesa holding) Company Information
13.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 McePharma (Vivesa holding) Main Business Overview
13.12.5 McePharma (Vivesa holding) Latest Developments
13.13 Cargill Incorporated
13.13.1 Cargill Incorporated Company Information
13.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Cargill Incorporated Main Business Overview
13.13.5 Cargill Incorporated Latest Developments
13.14 Daicel Corporation
13.14.1 Daicel Corporation Company Information
13.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Daicel Corporation Main Business Overview
13.14.5 Daicel Corporation Latest Developments
13.15 Anhui Sunhere Pharmaceutical
13.15.1 Anhui Sunhere Pharmaceutical Company Information
13.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Anhui Sunhere Pharmaceutical Main Business Overview
13.15.5 Anhui Sunhere Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Orally DisintegratingTablet Excipient Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Orally DisintegratingTablet Excipient Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Binders
Table 4. Major Players of Glidents
Table 5. Major Players of Diluents
Table 6. Major Players of Disintegrants
Table 7. Major Players of Others
Table 8. Global Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 9. Global Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Table 10. Global Orally DisintegratingTablet Excipient Revenue byType (2020-2025) & ($ million)
Table 11. Global Orally DisintegratingTablet Excipient Revenue Market Share byType (2020-2025)
Table 12. Global Orally DisintegratingTablet Excipient Sale Price byType (2020-2025) & (USD/MT)
Table 13. Global Orally DisintegratingTablet Excipient Sale by Application (2020-2025) & (K MT)
Table 14. Global Orally DisintegratingTablet Excipient Sale Market Share by Application (2020-2025)
Table 15. Global Orally DisintegratingTablet Excipient Revenue by Application (2020-2025) & ($ million)
Table 16. Global Orally DisintegratingTablet Excipient Revenue Market Share by Application (2020-2025)
Table 17. Global Orally DisintegratingTablet Excipient Sale Price by Application (2020-2025) & (USD/MT)
Table 18. Global Orally DisintegratingTablet Excipient Sales by Company (2020-2025) & (K MT)
Table 19. Global Orally DisintegratingTablet Excipient Sales Market Share by Company (2020-2025)
Table 20. Global Orally DisintegratingTablet Excipient Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Orally DisintegratingTablet Excipient Revenue Market Share by Company (2020-2025)
Table 22. Global Orally DisintegratingTablet Excipient Sale Price by Company (2020-2025) & (USD/MT)
Table 23. Key Manufacturers Orally DisintegratingTablet Excipient Producing Area Distribution and Sales Area
Table 24. Players Orally DisintegratingTablet Excipient Products Offered
Table 25. Orally DisintegratingTablet Excipient Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Orally DisintegratingTablet Excipient Sales by Geographic Region (2020-2025) & (K MT)
Table 29. Global Orally DisintegratingTablet Excipient Sales Market Share Geographic Region (2020-2025)
Table 30. Global Orally DisintegratingTablet Excipient Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Orally DisintegratingTablet Excipient Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Orally DisintegratingTablet Excipient Sales by Country/Region (2020-2025) & (K MT)
Table 33. Global Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2020-2025)
Table 34. Global Orally DisintegratingTablet Excipient Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Orally DisintegratingTablet Excipient Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 37. Americas Orally DisintegratingTablet Excipient Sales Market Share by Country (2020-2025)
Table 38. Americas Orally DisintegratingTablet Excipient Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 40. Americas Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 41. APAC Orally DisintegratingTablet Excipient Sales by Region (2020-2025) & (K MT)
Table 42. APAC Orally DisintegratingTablet Excipient Sales Market Share by Region (2020-2025)
Table 43. APAC Orally DisintegratingTablet Excipient Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 45. APAC Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 46. Europe Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 47. Europe Orally DisintegratingTablet Excipient Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 49. Europe Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 50. Middle East & Africa Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 51. Middle East & Africa Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 53. Middle East & Africa Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 54. Key Market Drivers & Growth Opportunities of Orally DisintegratingTablet Excipient
Table 55. Key Market Challenges & Risks of Orally DisintegratingTablet Excipient
Table 56. Key IndustryTrends of Orally DisintegratingTablet Excipient
Table 57. Orally DisintegratingTablet Excipient Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Orally DisintegratingTablet Excipient Distributors List
Table 60. Orally DisintegratingTablet Excipient Customer List
Table 61. Global Orally DisintegratingTablet Excipient SalesForecast by Region (2026-2031) & (K MT)
Table 62. Global Orally DisintegratingTablet Excipient RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 64. Americas Orally DisintegratingTablet Excipient Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Orally DisintegratingTablet Excipient SalesForecast by Region (2026-2031) & (K MT)
Table 66. APAC Orally DisintegratingTablet Excipient Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 68. Europe Orally DisintegratingTablet Excipient RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 70. Middle East & Africa Orally DisintegratingTablet Excipient RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Orally DisintegratingTablet Excipient SalesForecast byType (2026-2031) & (K MT)
Table 72. Global Orally DisintegratingTablet Excipient RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Orally DisintegratingTablet Excipient SalesForecast by Application (2026-2031) & (K MT)
Table 74. Global Orally DisintegratingTablet Excipient RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. BASF Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 76. BASF Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 77. BASF Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. BASF Main Business
Table 79. BASF Latest Developments
Table 80. JRS Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 81. JRS Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 82. JRS Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. JRS Pharma Main Business
Table 84. JRS Pharma Latest Developments
Table 85. Roquette Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 86. Roquette Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 87. Roquette Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Roquette Main Business
Table 89. Roquette Latest Developments
Table 90. ABF Ingredients Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 91. ABF Ingredients Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 92. ABF Ingredients Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. ABF Ingredients Main Business
Table 94. ABF Ingredients Latest Developments
Table 95. DFE Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 96. DFE Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 97. DFE Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. DFE Pharma Main Business
Table 99. DFE Pharma Latest Developments
Table 100. Evonik Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 101. Evonik Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 102. Evonik Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Evonik Main Business
Table 104. Evonik Latest Developments
Table 105. Merck KGaA Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck KGaA Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 107. Merck KGaA Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Merck KGaA Main Business
Table 109. Merck KGaA Latest Developments
Table 110. Ashland Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 111. Ashland Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 112. Ashland Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Ashland Main Business
Table 114. Ashland Latest Developments
Table 115. Meggle Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 116. Meggle Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 117. Meggle Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Meggle Pharma Main Business
Table 119. Meggle Pharma Latest Developments
Table 120. Shin-Etsu Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 121. Shin-Etsu Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 122. Shin-Etsu Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Shin-Etsu Main Business
Table 124. Shin-Etsu Latest Developments
Table 125.Fuji Chemical Industries Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 126.Fuji Chemical Industries Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 127.Fuji Chemical Industries Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128.Fuji Chemical Industries Main Business
Table 129.Fuji Chemical Industries Latest Developments
Table 130. McePharma (Vivesa holding) Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 131. McePharma (Vivesa holding) Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 132. McePharma (Vivesa holding) Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. McePharma (Vivesa holding) Main Business
Table 134. McePharma (Vivesa holding) Latest Developments
Table 135. Cargill Incorporated Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 136. Cargill Incorporated Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 137. Cargill Incorporated Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Cargill Incorporated Main Business
Table 139. Cargill Incorporated Latest Developments
Table 140. Daicel Corporation Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 141. Daicel Corporation Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 142. Daicel Corporation Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Daicel Corporation Main Business
Table 144. Daicel Corporation Latest Developments
Table 145. Anhui Sunhere Pharmaceutical Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 146. Anhui Sunhere Pharmaceutical Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 147. Anhui Sunhere Pharmaceutical Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 148. Anhui Sunhere Pharmaceutical Main Business
Table 149. Anhui Sunhere Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Orally DisintegratingTablet Excipient
Figure 2. Orally DisintegratingTablet Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orally DisintegratingTablet Excipient Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Orally DisintegratingTablet Excipient Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Orally DisintegratingTablet Excipient Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2024)
Figure 10. Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Binders
Figure 12. Product Picture of Glidents
Figure 13. Product Picture of Diluents
Figure 14. Product Picture of Disintegrants
Figure 15. Product Picture of Others
Figure 16. Global Orally DisintegratingTablet Excipient Sales Market Share byType in 2025
Figure 17. Global Orally DisintegratingTablet Excipient Revenue Market Share byType (2020-2025)
Figure 18. Orally DisintegratingTablet Excipient Consumed in Anti-Psychotics Drug
Figure 19. Global Orally DisintegratingTablet Excipient Market: Anti-Psychotics Drug (2020-2025) & (K MT)
Figure 20. Orally DisintegratingTablet Excipient Consumed in Anti-Epileptics Drug
Figure 21. Global Orally DisintegratingTablet Excipient Market: Anti-Epileptics Drug (2020-2025) & (K MT)
Figure 22. Orally DisintegratingTablet Excipient Consumed in Others
Figure 23. Global Orally DisintegratingTablet Excipient Market: Others (2020-2025) & (K MT)
Figure 24. Global Orally DisintegratingTablet Excipient Sale Market Share by Application (2024)
Figure 25. Global Orally DisintegratingTablet Excipient Revenue Market Share by Application in 2025
Figure 26. Orally DisintegratingTablet Excipient Sales by Company in 2025 (K MT)
Figure 27. Global Orally DisintegratingTablet Excipient Sales Market Share by Company in 2025
Figure 28. Orally DisintegratingTablet Excipient Revenue by Company in 2025 ($ millions)
Figure 29. Global Orally DisintegratingTablet Excipient Revenue Market Share by Company in 2025
Figure 30. Global Orally DisintegratingTablet Excipient Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Orally DisintegratingTablet Excipient Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 33. Americas Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 34. APAC Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 35. APAC Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 36. Europe Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 37. Europe Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 39. Middle East & Africa Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 40. Americas Orally DisintegratingTablet Excipient Sales Market Share by Country in 2025
Figure 41. Americas Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Figure 42. Americas Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 43. Americas Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 44. United States Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Orally DisintegratingTablet Excipient Sales Market Share by Region in 2025
Figure 49. APAC Orally DisintegratingTablet Excipient Revenue Market Share by Region (2020-2025)
Figure 50. APAC Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 51. APAC Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 52. China Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 56. India Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Orally DisintegratingTablet Excipient Sales Market Share by Country in 2025
Figure 60. Europe Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Figure 61. Europe Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 62. Europe Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 63. Germany Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 64.France Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 71. Egypt Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Orally DisintegratingTablet Excipient in 2025
Figure 77. Manufacturing Process Analysis of Orally DisintegratingTablet Excipient
Figure 78. Industry Chain Structure of Orally DisintegratingTablet Excipient
Figure 79. Channels of Distribution
Figure 80. Global Orally DisintegratingTablet Excipient Sales MarketForecast by Region (2026-2031)
Figure 81. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Orally DisintegratingTablet Excipient Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Orally DisintegratingTablet Excipient Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Country/Region, 2020, 2024 & 2031
2.2 Orally Disintegrating Tablet Excipient Segment by Type
2.2.1 Binders
2.2.2 Glidents
2.2.3 Diluents
2.2.4 Disintegrants
2.2.5 Others
2.3 Orally Disintegrating Tablet Excipient Sales by Type
2.3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
2.3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2020-2025)
2.3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2020-2025)
2.4 Orally Disintegrating Tablet Excipient Segment by Application
2.4.1 Anti-Psychotics Drug
2.4.2 Anti-Epileptics Drug
2.4.3 Others
2.5 Orally Disintegrating Tablet Excipient Sales by Application
2.5.1 Global Orally Disintegrating Tablet Excipient Sale Market Share by Application (2020-2025)
2.5.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Application (2020-2025)
2.5.3 Global Orally Disintegrating Tablet Excipient Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Orally Disintegrating Tablet Excipient Breakdown Data by Company
3.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Company (2020-2025)
3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2020-2025)
3.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Company (2020-2025)
3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Company (2020-2025)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2020-2025)
3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Company
3.4 Key Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orally Disintegrating Tablet Excipient Product Location Distribution
3.4.2 Players Orally Disintegrating Tablet Excipient Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORALLY DISINTEGRATING TABLET EXCIPIENT BY GEOGRAPHIC REGION
4.1 World Historic Orally Disintegrating Tablet Excipient Market Size by Geographic Region (2020-2025)
4.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Orally Disintegrating Tablet Excipient Market Size by Country/Region (2020-2025)
4.2.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Country/Region (2020-2025)
4.2.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Country/Region (2020-2025)
4.3 Americas Orally Disintegrating Tablet Excipient Sales Growth
4.4 APAC Orally Disintegrating Tablet Excipient Sales Growth
4.5 Europe Orally Disintegrating Tablet Excipient Sales Growth
4.6 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Growth
5 AMERICAS
5.1 Americas Orally Disintegrating Tablet Excipient Sales by Country
5.1.1 Americas Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
5.1.2 Americas Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
5.2 Americas Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
5.3 Americas Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orally Disintegrating Tablet Excipient Sales by Region
6.1.1 APAC Orally Disintegrating Tablet Excipient Sales by Region (2020-2025)
6.1.2 APAC Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025)
6.2 APAC Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
6.3 APAC Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
7.2 Europe Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
7.3 Europe Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Orally Disintegrating Tablet Excipient by Country
8.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2025)
8.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025)
8.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
8.3 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet Excipient
10.3 Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
10.4 Industry Chain Structure of Orally Disintegrating Tablet Excipient
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orally Disintegrating Tablet Excipient Distributors
11.3 Orally Disintegrating Tablet Excipient Customer
12 WORLD FORECAST REVIEW FOR ORALLY DISINTEGRATING TABLET EXCIPIENT BY GEOGRAPHIC REGION
12.1 Global Orally Disintegrating Tablet Excipient Market Size Forecast by Region
12.1.1 Global Orally Disintegrating Tablet Excipient Forecast by Region (2026-2031)
12.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Orally Disintegrating Tablet Excipient Forecast by Type (2026-2031)
12.7 Global Orally Disintegrating Tablet Excipient Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 JRS Pharma
13.2.1 JRS Pharma Company Information
13.2.2 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 JRS Pharma Main Business Overview
13.2.5 JRS Pharma Latest Developments
13.3 Roquette
13.3.1 Roquette Company Information
13.3.2 Roquette Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roquette Main Business Overview
13.3.5 Roquette Latest Developments
13.4 ABF Ingredients
13.4.1 ABF Ingredients Company Information
13.4.2 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 ABF Ingredients Main Business Overview
13.4.5 ABF Ingredients Latest Developments
13.5 DFE Pharma
13.5.1 DFE Pharma Company Information
13.5.2 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 DFE Pharma Main Business Overview
13.5.5 DFE Pharma Latest Developments
13.6 Evonik
13.6.1 Evonik Company Information
13.6.2 Evonik Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Evonik Main Business Overview
13.6.5 Evonik Latest Developments
13.7 Merck KGaA
13.7.1 Merck KGaA Company Information
13.7.2 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck KGaA Main Business Overview
13.7.5 Merck KGaA Latest Developments
13.8 Ashland
13.8.1 Ashland Company Information
13.8.2 Ashland Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ashland Main Business Overview
13.8.5 Ashland Latest Developments
13.9 Meggle Pharma
13.9.1 Meggle Pharma Company Information
13.9.2 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Meggle Pharma Main Business Overview
13.9.5 Meggle Pharma Latest Developments
13.10 Shin-Etsu
13.10.1 Shin-Etsu Company Information
13.10.2 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Shin-Etsu Main Business Overview
13.10.5 Shin-Etsu Latest Developments
13.11 Fuji Chemical Industries
13.11.1 Fuji Chemical Industries Company Information
13.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Fuji Chemical Industries Main Business Overview
13.11.5 Fuji Chemical Industries Latest Developments
13.12 McePharma (Vivesa holding)
13.12.1 McePharma (Vivesa holding) Company Information
13.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 McePharma (Vivesa holding) Main Business Overview
13.12.5 McePharma (Vivesa holding) Latest Developments
13.13 Cargill Incorporated
13.13.1 Cargill Incorporated Company Information
13.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Cargill Incorporated Main Business Overview
13.13.5 Cargill Incorporated Latest Developments
13.14 Daicel Corporation
13.14.1 Daicel Corporation Company Information
13.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Daicel Corporation Main Business Overview
13.14.5 Daicel Corporation Latest Developments
13.15 Anhui Sunhere Pharmaceutical
13.15.1 Anhui Sunhere Pharmaceutical Company Information
13.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolios and Specifications
13.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Anhui Sunhere Pharmaceutical Main Business Overview
13.15.5 Anhui Sunhere Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Orally DisintegratingTablet Excipient Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Orally DisintegratingTablet Excipient Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Binders
Table 4. Major Players of Glidents
Table 5. Major Players of Diluents
Table 6. Major Players of Disintegrants
Table 7. Major Players of Others
Table 8. Global Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 9. Global Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Table 10. Global Orally DisintegratingTablet Excipient Revenue byType (2020-2025) & ($ million)
Table 11. Global Orally DisintegratingTablet Excipient Revenue Market Share byType (2020-2025)
Table 12. Global Orally DisintegratingTablet Excipient Sale Price byType (2020-2025) & (USD/MT)
Table 13. Global Orally DisintegratingTablet Excipient Sale by Application (2020-2025) & (K MT)
Table 14. Global Orally DisintegratingTablet Excipient Sale Market Share by Application (2020-2025)
Table 15. Global Orally DisintegratingTablet Excipient Revenue by Application (2020-2025) & ($ million)
Table 16. Global Orally DisintegratingTablet Excipient Revenue Market Share by Application (2020-2025)
Table 17. Global Orally DisintegratingTablet Excipient Sale Price by Application (2020-2025) & (USD/MT)
Table 18. Global Orally DisintegratingTablet Excipient Sales by Company (2020-2025) & (K MT)
Table 19. Global Orally DisintegratingTablet Excipient Sales Market Share by Company (2020-2025)
Table 20. Global Orally DisintegratingTablet Excipient Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Orally DisintegratingTablet Excipient Revenue Market Share by Company (2020-2025)
Table 22. Global Orally DisintegratingTablet Excipient Sale Price by Company (2020-2025) & (USD/MT)
Table 23. Key Manufacturers Orally DisintegratingTablet Excipient Producing Area Distribution and Sales Area
Table 24. Players Orally DisintegratingTablet Excipient Products Offered
Table 25. Orally DisintegratingTablet Excipient Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Orally DisintegratingTablet Excipient Sales by Geographic Region (2020-2025) & (K MT)
Table 29. Global Orally DisintegratingTablet Excipient Sales Market Share Geographic Region (2020-2025)
Table 30. Global Orally DisintegratingTablet Excipient Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Orally DisintegratingTablet Excipient Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Orally DisintegratingTablet Excipient Sales by Country/Region (2020-2025) & (K MT)
Table 33. Global Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2020-2025)
Table 34. Global Orally DisintegratingTablet Excipient Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Orally DisintegratingTablet Excipient Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 37. Americas Orally DisintegratingTablet Excipient Sales Market Share by Country (2020-2025)
Table 38. Americas Orally DisintegratingTablet Excipient Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 40. Americas Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 41. APAC Orally DisintegratingTablet Excipient Sales by Region (2020-2025) & (K MT)
Table 42. APAC Orally DisintegratingTablet Excipient Sales Market Share by Region (2020-2025)
Table 43. APAC Orally DisintegratingTablet Excipient Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 45. APAC Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 46. Europe Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 47. Europe Orally DisintegratingTablet Excipient Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 49. Europe Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 50. Middle East & Africa Orally DisintegratingTablet Excipient Sales by Country (2020-2025) & (K MT)
Table 51. Middle East & Africa Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Orally DisintegratingTablet Excipient Sales byType (2020-2025) & (K MT)
Table 53. Middle East & Africa Orally DisintegratingTablet Excipient Sales by Application (2020-2025) & (K MT)
Table 54. Key Market Drivers & Growth Opportunities of Orally DisintegratingTablet Excipient
Table 55. Key Market Challenges & Risks of Orally DisintegratingTablet Excipient
Table 56. Key IndustryTrends of Orally DisintegratingTablet Excipient
Table 57. Orally DisintegratingTablet Excipient Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Orally DisintegratingTablet Excipient Distributors List
Table 60. Orally DisintegratingTablet Excipient Customer List
Table 61. Global Orally DisintegratingTablet Excipient SalesForecast by Region (2026-2031) & (K MT)
Table 62. Global Orally DisintegratingTablet Excipient RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 64. Americas Orally DisintegratingTablet Excipient Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Orally DisintegratingTablet Excipient SalesForecast by Region (2026-2031) & (K MT)
Table 66. APAC Orally DisintegratingTablet Excipient Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 68. Europe Orally DisintegratingTablet Excipient RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Orally DisintegratingTablet Excipient SalesForecast by Country (2026-2031) & (K MT)
Table 70. Middle East & Africa Orally DisintegratingTablet Excipient RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Orally DisintegratingTablet Excipient SalesForecast byType (2026-2031) & (K MT)
Table 72. Global Orally DisintegratingTablet Excipient RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Orally DisintegratingTablet Excipient SalesForecast by Application (2026-2031) & (K MT)
Table 74. Global Orally DisintegratingTablet Excipient RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. BASF Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 76. BASF Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 77. BASF Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. BASF Main Business
Table 79. BASF Latest Developments
Table 80. JRS Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 81. JRS Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 82. JRS Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. JRS Pharma Main Business
Table 84. JRS Pharma Latest Developments
Table 85. Roquette Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 86. Roquette Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 87. Roquette Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Roquette Main Business
Table 89. Roquette Latest Developments
Table 90. ABF Ingredients Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 91. ABF Ingredients Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 92. ABF Ingredients Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. ABF Ingredients Main Business
Table 94. ABF Ingredients Latest Developments
Table 95. DFE Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 96. DFE Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 97. DFE Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. DFE Pharma Main Business
Table 99. DFE Pharma Latest Developments
Table 100. Evonik Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 101. Evonik Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 102. Evonik Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Evonik Main Business
Table 104. Evonik Latest Developments
Table 105. Merck KGaA Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck KGaA Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 107. Merck KGaA Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Merck KGaA Main Business
Table 109. Merck KGaA Latest Developments
Table 110. Ashland Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 111. Ashland Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 112. Ashland Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Ashland Main Business
Table 114. Ashland Latest Developments
Table 115. Meggle Pharma Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 116. Meggle Pharma Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 117. Meggle Pharma Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Meggle Pharma Main Business
Table 119. Meggle Pharma Latest Developments
Table 120. Shin-Etsu Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 121. Shin-Etsu Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 122. Shin-Etsu Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Shin-Etsu Main Business
Table 124. Shin-Etsu Latest Developments
Table 125.Fuji Chemical Industries Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 126.Fuji Chemical Industries Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 127.Fuji Chemical Industries Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128.Fuji Chemical Industries Main Business
Table 129.Fuji Chemical Industries Latest Developments
Table 130. McePharma (Vivesa holding) Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 131. McePharma (Vivesa holding) Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 132. McePharma (Vivesa holding) Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. McePharma (Vivesa holding) Main Business
Table 134. McePharma (Vivesa holding) Latest Developments
Table 135. Cargill Incorporated Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 136. Cargill Incorporated Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 137. Cargill Incorporated Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Cargill Incorporated Main Business
Table 139. Cargill Incorporated Latest Developments
Table 140. Daicel Corporation Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 141. Daicel Corporation Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 142. Daicel Corporation Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Daicel Corporation Main Business
Table 144. Daicel Corporation Latest Developments
Table 145. Anhui Sunhere Pharmaceutical Basic Information, Orally DisintegratingTablet Excipient Manufacturing Base, Sales Area and Its Competitors
Table 146. Anhui Sunhere Pharmaceutical Orally DisintegratingTablet Excipient Product Portfolios and Specifications
Table 147. Anhui Sunhere Pharmaceutical Orally DisintegratingTablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 148. Anhui Sunhere Pharmaceutical Main Business
Table 149. Anhui Sunhere Pharmaceutical Latest Developments
LIST OFFIGURES
Figure 1. Picture of Orally DisintegratingTablet Excipient
Figure 2. Orally DisintegratingTablet Excipient Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orally DisintegratingTablet Excipient Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Orally DisintegratingTablet Excipient Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Orally DisintegratingTablet Excipient Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2024)
Figure 10. Orally DisintegratingTablet Excipient Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Binders
Figure 12. Product Picture of Glidents
Figure 13. Product Picture of Diluents
Figure 14. Product Picture of Disintegrants
Figure 15. Product Picture of Others
Figure 16. Global Orally DisintegratingTablet Excipient Sales Market Share byType in 2025
Figure 17. Global Orally DisintegratingTablet Excipient Revenue Market Share byType (2020-2025)
Figure 18. Orally DisintegratingTablet Excipient Consumed in Anti-Psychotics Drug
Figure 19. Global Orally DisintegratingTablet Excipient Market: Anti-Psychotics Drug (2020-2025) & (K MT)
Figure 20. Orally DisintegratingTablet Excipient Consumed in Anti-Epileptics Drug
Figure 21. Global Orally DisintegratingTablet Excipient Market: Anti-Epileptics Drug (2020-2025) & (K MT)
Figure 22. Orally DisintegratingTablet Excipient Consumed in Others
Figure 23. Global Orally DisintegratingTablet Excipient Market: Others (2020-2025) & (K MT)
Figure 24. Global Orally DisintegratingTablet Excipient Sale Market Share by Application (2024)
Figure 25. Global Orally DisintegratingTablet Excipient Revenue Market Share by Application in 2025
Figure 26. Orally DisintegratingTablet Excipient Sales by Company in 2025 (K MT)
Figure 27. Global Orally DisintegratingTablet Excipient Sales Market Share by Company in 2025
Figure 28. Orally DisintegratingTablet Excipient Revenue by Company in 2025 ($ millions)
Figure 29. Global Orally DisintegratingTablet Excipient Revenue Market Share by Company in 2025
Figure 30. Global Orally DisintegratingTablet Excipient Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Orally DisintegratingTablet Excipient Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 33. Americas Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 34. APAC Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 35. APAC Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 36. Europe Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 37. Europe Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Orally DisintegratingTablet Excipient Sales 2020-2025 (K MT)
Figure 39. Middle East & Africa Orally DisintegratingTablet Excipient Revenue 2020-2025 ($ millions)
Figure 40. Americas Orally DisintegratingTablet Excipient Sales Market Share by Country in 2025
Figure 41. Americas Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Figure 42. Americas Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 43. Americas Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 44. United States Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Orally DisintegratingTablet Excipient Sales Market Share by Region in 2025
Figure 49. APAC Orally DisintegratingTablet Excipient Revenue Market Share by Region (2020-2025)
Figure 50. APAC Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 51. APAC Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 52. China Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 56. India Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Orally DisintegratingTablet Excipient Sales Market Share by Country in 2025
Figure 60. Europe Orally DisintegratingTablet Excipient Revenue Market Share by Country (2020-2025)
Figure 61. Europe Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 62. Europe Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 63. Germany Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 64.France Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Orally DisintegratingTablet Excipient Sales Market Share by Application (2020-2025)
Figure 71. Egypt Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Orally DisintegratingTablet Excipient Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Orally DisintegratingTablet Excipient in 2025
Figure 77. Manufacturing Process Analysis of Orally DisintegratingTablet Excipient
Figure 78. Industry Chain Structure of Orally DisintegratingTablet Excipient
Figure 79. Channels of Distribution
Figure 80. Global Orally DisintegratingTablet Excipient Sales MarketForecast by Region (2026-2031)
Figure 81. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Orally DisintegratingTablet Excipient Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Orally DisintegratingTablet Excipient Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Orally DisintegratingTablet Excipient Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Medical Brachytherapy Device Market Growth 2024-2030
US$ 3,660.00
March 2024
114 pages
Global Day Case Surgery Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
93 pages
Global Alfuzosin Market Growth 2025-2031
US$ 3,660.00
December 2025
96 pages
Global Emergency Contraceptive Pills Market Growth 2025-2031
US$ 3,660.00
January 2024
116 pages
